GPCR FMR LLC sells $3.2M worth of shares
Dec 11, 2025, 5:38 AM
0.00%
What does GPCR do
Structure Therapeutics, a clinical stage biopharmaceutical company based in South San Francisco, focuses on developing oral therapeutics targeting GPCRs for chronic diseases. It went public on February 3, 2023, and employs 111 people.
FMR LLC sold 52,356 shares of GPCR on 8 December at $61.45 per share, worth a total of $3.2M. They now own 39,918 GPCR shares, or a 100% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.